Citations

Clear

3314 citation(s) found for "Do, Alexander".

Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Abdelbaky, Salma , Giacopelli, Brian , Rabe, Kari G. , Yamaguchi, Kyoko , Wu, Yue-Zhong, Yan, Huihuang , Shanafelt, Tait D. , Parikh, Sameer A. , Hampel, Paul J. , Brown, Sochilt , Vachon, Celine M. , Hanson, Curtis A. , Parker, Alexander S. , Oakes, Christopher C. , Ding, Wei , Hampel, Paul J , Cerhan, James R , Vachon, Celine M. , Kay, Neil E , Braggio, Esteban , Slager, Susan L , Oakes, Christopher C , Chaffee, Kari G. , Ding, Wei , Parikh, Sameer A , Shanafelt, Tait D , Ding, Wei , Cerhan, James R. , Kay, Neil E. , Braggio, Esteban , Slager, Susan L.

Mayo Clinic

Blood | January 9, 2024 | Volume: 143 | Issue: 17 | Pages: 1752-1757

10.1182/blood.2023022180 | PMID 38194687 Get It

Abstract Monoclonal B-cell lymphocytosis (MBL) progresses to chronic lymphocytic leukemia (CLL) requiring therapy at 1% to 5% per year. Improved prediction of progression would greatly benefit individuals with MBL. Patients with CLL separate into 3 distinct epigenetic subtypes (epitypes) with high prognostic significance, and recently the intermediate epitype has been shown to be enriched for high-risk immunoglobulin lambda variable (IGLV) 3-21 rearrangements, impacting outcomes for these patients. Here, we employed this combined strategy to generate the epigenetic and light chain immunoglobulin (ELCLV3-21) signature to classify 219 individuals with MBL. The ELCLV3-21 high-risk signature distinguished MBL individuals with a high probability of progression (39.9% and 71.1% at 5 and 10 years, respectively). ELCLV3-21 improved the accuracy of predicting time to therapy for individuals with MBL compared with other established prognostic indicators, including the CLL international prognostic index (c-statistic, 0.767 vs 0.668, respectively). Comparing ELCLV3-21 risk groups in MBL vs a cohort of 226 patients with CLL revealed ELCLV3-21 high-risk individuals with MBL had significantly shorter time to therapy (P = .003) and reduced overall survival (P = .03) compared with ELCLV3-21 low-risk individuals with CLL. These results highlight the power of the ELCLV3-21 approach to identify individuals with a higher likelihood of adverse clinical outcome and may provide a more accurate approach to classify individuals with small B-cell clones.
Stretch response of the mechano-gated channel TMEM63A in membrane patches and single cells
Niloy, Sayeman Islam , Hannan, Elizabeth , Cowan, Luke M. , Linsenmeier, Fabian, Friedrich, Oliver , Farrugia, Gianrico , Beyder, Arthur , Strege, Peter R , Hannan, Elizabeth C, Cowan, Luke M , Farrugia, Gianrico , Beyder, Arthur , Strege, Peter R.

Mayo Clinic

American Journal of Physiology-Cell Physiology | January 8, 2024 | Volume: 326 | Issue: 2 | Pages: C622-C631

10.1152/ajpcell.00583.2023 | PMID 38189136 Get It

TMEM63A has biophysical features distinctive for mechano-gated cation channels, but some properties are less clear, including no functional information in whole cells. We report that pressure-dependent yet voltage-independent TMEM63A currents in cell membrane patches correlated with cell size. In addition, radial stretch of whole cells on flexible membranes increased the [Ca2+]i responses more in TMEM63A-transfected cells. Inward TMEM63A currents in response to high stretch can depolarize plasma membranes and contribute to a sustained [Ca2+]i increase.
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer
Seyedi, Sareh , Teo, Ruthanne, Foster, Luke , Saha, Daniel , Mina, Lida A. , Northfelt, Donald W. , Anderson, Karen S. , Gatenby, Robert A. , Cisneros, Luis , Troan, Brigid V. , Anderson, Alexander R.A. , Maley, Carlo C. , Mina, Lida, Gatenby, Robert , Cisneros, Luis H , Troan, Brigid , Anderson, Alexander R A , Maley, Carlo C. , Foster, Luke, Shibata, Darryl K.

Mayo Clinic

Cancers | January 8, 2024 | Volume: 16 | Issue: 2 | Pages: 257

10.3390/cancers16020257 | PMID 38254748 Get It

Adaptive therapy, an ecologically inspired approach to cancer treatment, aims to overcome resistance and reduce toxicity by leveraging competitive interactions between drug-sensitive and drug-resistant subclones, prioritizing patient survival and quality of life instead of killing the maximum number of cancer cells. In preparation for a clinical trial, we used endocrine-resistant MCF7 breast cancer to stimulate second-line therapy and tested adaptive therapy using capecitabine, gemcitabine, or their combination in a mouse xenograft model. Dose modulation adaptive therapy with capecitabine alone increased survival time relative to MTD but not statistically significantly (HR = 0.22, 95% CI = 0.043–1.1, p = 0.065). However, when we alternated the drugs in both dose modulation (HR = 0.11, 95% CI = 0.024–0.55, p = 0.007) and intermittent adaptive therapies, the survival time was significantly increased compared to high-dose combination therapy (HR = 0.07, 95% CI = 0.013–0.42, p = 0.003). Overall, the survival time increased with reduced dose for both single drugs (p < 0.01) and combined drugs (p < 0.001), resulting in tumors with fewer proliferation cells (p = 0.0026) and more apoptotic cells (p = 0.045) compared to high-dose therapy. Adaptive therapy favors slower-growing tumors and shows promise in two-drug alternating regimens instead of being combined.
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
Rejeski, Kai , Wang, Yucai , Iacoboni, Gloria , Bachy, Emmanuel , Bansal, Radhika , Penack, Olaf , Müller, Fabian , Bethge, Wolfgang , Mohty, Razan , Bücklein, Veit , Barba, Pere , Lin, Yi , Iacoboni, Gloria , Bachy, Emmanuel , Bansal, Radhika , Müller, Fabian , Bethge, Wolfgang , Bücklein, Veit L , Jain, Michael D , Subklewe, Marion , Wang, Yucai , Hansen, Doris K. , Muñoz, Javier , Locke, Frederick L. , Jain, Michael D.

Mayo Clinic

Blood Advances | January 5, 2024 | Volume: 8 | Issue: 8 | Pages: 1857-1868

10.1182/bloodadvances.2023011767 | PMID 38181508 Get It

Abstract Cytopenias represent the most common side effect of CAR T-cell therapy (CAR-T) and can predispose for severe infectious complications. Current grading systems, such as the Common Terminology Criteria for Adverse Events (CTCAE), neither reflect the unique quality of post–CAR-T neutrophil recovery, nor do they reflect the inherent risk of infections due to protracted neutropenia. For this reason, a novel EHA/EBMT consensus grading was recently developed for Immune Effector Cell-Associated HematoToxicity (ICAHT). In this multicenter, observational study, we applied the grading system to a large real-world cohort of 549 patients treated with BCMA- or CD19-directed CAR-T for refractory B-cell malignancies (112 multiple myeloma [MM], 334 large B-cell lymphoma [LBCL], 103 mantle cell lymphoma [MCL]) and examined the clinical sequelae of severe (≥3°) ICAHT. The ICAHT grading was strongly associated with the cumulative duration of severe neutropenia (r = 0.92, P &lt; .0001), the presence of multilineage cytopenias, and the use of platelet and red blood cell transfusions. We noted an increased rate of severe ICAHT in patients with MCL vs those with LBCL and MM (28% vs 23% vs 15%). Severe ICAHT was associated with a higher rate of severe infections (49% vs 13%, P &lt; .0001), increased nonrelapse mortality (14% vs 4%, P &lt; .0001), and inferior survival outcomes (1-year progression-free survival: 35% vs 51%, 1-year overall survival: 52% vs 73%, both P &lt; .0001). Importantly, the ICAHT grading demonstrated superior capacity to predict severe infections compared with the CTCAE grading (c-index 0.73 vs 0.55, P &lt; .0001 vs nonsignificant). Taken together, these data highlight the clinical relevance of the novel grading system and support the reporting of ICAHT severity in clinical trials evaluating CAR-T therapies.
Ink-Spiring Innovations: 3D Bioprinting Skin Models for Disease Discovery
Torigoe, Rafaela Mayumi Simoes , Revzin, Alexander , Wyles, Saranya P. , Simoes Torigoe, Rafaela Mayumi , Badley, Andrew, Wyles, Saranya, Badley, Andrew D.

Mayo Clinic

Regenerative Medicine | January 5, 2024 | Volume: 19 | Issue: 2 | Pages: 65-68

10.2217/rme-2023-0216 | PMID 38179985 Get It

Virology—the path forward
Grönvall, Gigi Kwik , Lowen, Anice C. , Goodrum, Felicia , Alwine, James C. , Andersen, Kristian G. , Anthony, Simon J. , Baines, Joel D. , Banerjee, Arinjay , Broadbent, Andrew J. , Brooke, Christopher B. , Campos, Samuel K. , Caposio, Patrizia , Chan, Gary C. , Collins-McMillen, Donna , Connell, Nancy , Damania, Blossom , Daugherty, Matthew D. , Dermody, Terence S. , Galloway, Denise A. , Hartman, Amy L. , Hogue, Brenda G. , Jung, Jae U. , Karst, Stephanie M. , Laimins, Lou, Landais, Igor, Lindenbach, Brett D. , Luftig, Micah A. , Mehle, Andrew , Moscona, Anne , Münger, Karl , Nikolich‐Žugich, Janko , Popescu, Saskia , Racaniello, Vincent R. , Rice, Charles M. , Runstadler, Jonathan A. , Sapp, Martin , Scott, Rona S. , Streblow, Daniel N. , Doorslaer, Koenraad Van , White, Elizabeth , White, Timothy M. , Worobey, Michael , Yamaoka, Satoko , Rasmussen, Angela L , Gronvall, Gigi K , Lowen, Anice C , Goodrum, Felicia , Baines, Joel , Banerjee, Arinjay , Broadbent, Andrew J , Brooke, Christopher B , Campos, Samuel K , Caposio, Patrizia , Casadevall, Arturo , Chan, Gary C , Cliffe, Anna R , Damania, Blossom , Dermody, Terence S , DiMaio, Daniel , Duprex, W Paul , Greninger, Alexander L , Hartman, Amy L , Horner, Stacy M , Jung, Jae U , Kamil, Jeremy P , Laimins, Lou , Lakdawala, Seema S , Letko, Michael , Liu, Shan-Lu , Luftig, Micah , McFadden, Grant , Mehle, Andrew , Moscona, Anne , Munger, Joshua , Murphy, Eain , O'Connor, Christine M , Pekosz, Andrew , Permar, Sallie R , Pfeiffer, Julie K , Purdy, John G , Runstadler, Jonathan A , Sapp, Martin J , Scott, Rona S , Smith, Gregory A , Tibbetts, Scott A , Toth, Zsolt , Weiss, Susan R , White, Elizabeth A , Wobus, Christiane E , Yurochko, Andrew , Nikolich, Janko Z , Casadevall, Arturo , Debbink, Kari M. , Duprex, W. Paul , Emerman, Michael , Garry, Robert F. , Goldstein, Stephen A. , Greninger, Alexander L. , Hotez, Peter Jay , Morrison, Juliet , Mühlberger, Elke , Neufeldt, Christopher John , O’Connor, Christine M. , Permar, Sallie R. , Sorrell, Erin M. , Speranza, Emily E. , Wobus, Christiane E.

Mayo Clinic

Journal of Virology | January 3, 2024 | Volume: 98 | Issue: 1 | Pages: No page available

10.1128/jvi.01791-23 | PMID 38168672 Get It

ABSTRACT In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.
Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma
Gânier, Clarisse , Herrera-Oropeza, Gabriel, Du-Harpur, Xinyi , Blakeley, Matthew , Gabriel, Jeyrroy , Predeus, Alexander V. , Prete, Martin , Harun, Nasrat, Darrigrand, Jean-François , Haiser, Alexander , Wyles, Saranya P. , Teichmann, Sarah A. , Wyles, Saranya, Watt, Fiona M , Mazin, Pavel , Çakır, Batuhan , Shaw, Tanya J. , Haniffa, Muzlifah A. , Lynch, Magnus

Mayo Clinic

Proceedings of the National Academy of Sciences | January 2, 2024 | Volume: 121 | Issue: 2 | Pages: No page available

10.1073/pnas.2313326120 | PMID 38165934 Get It

Our understanding of how human skin cells differ according to anatomical site and tumour formation is limited. To address this, we have created a multiscale spatial atlas of healthy skin and basal cell carcinoma (BCC), incorporating in vivo optical coherence tomography, single-cell RNA sequencing, spatial global transcriptional profiling, and in situ sequencing. Computational spatial deconvolution and projection revealed the localisation of distinct cell populations to specific tissue contexts. Although cell populations were conserved between healthy anatomical sites and in BCC, mesenchymal cell populations including fibroblasts and pericytes retained signatures of developmental origin. Spatial profiling and in silico lineage tracing support a hair follicle origin for BCC and demonstrate that cancer-associated fibroblasts are an expansion of a POSTN + subpopulation associated with hair follicles in healthy skin. RGS5+ pericytes are also expanded in BCC suggesting a role in vascular remodelling. We propose that the identity of mesenchymal cell populations is regulated by signals emanating from adjacent structures and that these signals are repurposed to promote the expansion of skin cancer stroma. The resource we have created is publicly available in an interactive format for the research community.
Minimally Invasive Quadriceps Tendon Anterior Cruciate Ligament Reconstruction Using the Quadriceps Tendon Harvest Guide System
Dancy, Malik E. , Davis, Michelle A. , Meta, Fabien , Wang, Allen S. , Boos, Alexander M. , Camp, Christopher L. , Hevesi, Mario , Okoroha, Kelechi R. , Camp, Christopher L. , Wang, Allen , Boos, Alexander , Hevesi, Mario , Davis, Michelle A.

Mayo Clinic

Arthroscopy Techniques | January 1, 2024 | Volume: 13 | Issue: 3 | Pages: No page available

10.1016/j.eats.2023.11.009 | PMID 38584636 Get It

Abstract Anterior cruciate ligament (ACL) reconstruction using the quadriceps tendon (QT) autograft is an increasingly utilized technique that confers less donor site morbidity and comparable outcomes to other historically used graft options. The graft harvest and implantation process present vast variability—particularly regarding the achievement of adequate graft site visualization, consistently attaining a uniform and appropriately sized graft, and subsequent reconstruction of the ACL with the all‐soft tissue graft. The purpose of this Technical Note and video is to describe and demonstrate minimally invasive quadriceps tendon autograft harvesting using the Quadriceps Tendon Harvest Guide System (QUADTRAC), and its subsequent implantation within a single‐bundle ACL reconstruction with suspensory fixation. Technique Video video See video under supplementary data.
Exercise Catheterization in Adults Post-Fontan with Normal and Abnormal Haemodynamic Criteria: Insights Into Normal Fontan Physiology
Miranda, William R. , Jain, C. Charles , Connolly, Heidi M. , Bruaene, Alexander Van De , Egbe, Alexander C. , Borlaug, Barry A. , Burchill, Luke J.

Mayo Clinic

European Journal of Heart Failure | December 29, 2023 | Volume: 26 | Issue: 2 | Pages: 314-323

10.1002/ejhf.3119 | PMID 38155533 Get It

Abstract Aim The normal (i.e. expected) haemodynamics in adults post-Fontan remain poorly delineated. Moreover, the definitions of elevated exercise pulmonary artery (PA) and PA wedge pressure (PAWP) for this population have not been described. Methods and results Seventy-two adults post-Fontan undergoing exercise catheterization were categorized into abnormal (Group I, n = 59; defined as resting mean PA ≥14 mmHg and/or PAWP ≥12 mmHg, ΔPAWP/Δsystemic flow [Qs] &gt;2 mmHg/L/min, and/or ΔPA/Δpulmonary flow &gt;3 mmHg/L/min) and normal (Group II, n = 13) haemodynamics. Thirty-nine patients with non-cardiac dyspnoea (NCD) were included as controls. There was no difference in exercise arterial oxygen saturation (87% [81–92] vs. 89% [85–93], p = 0.29), while exercise PA pressure (27 [23–31] vs. 16 [14.5–19.5] mmHg, p &lt; 0.001) and PAWP were higher (21 [18–28] vs. 12 [8–14] mmHg, p &lt; 0.001) in Group I. At peak exercise, Group I had lower heart rate (97 [81–120] vs. 133 [112.5–147.5] bpm, p &lt; 0.001) and Qs response (67.3 [43.8–93.1] vs. 105.9 (82–118.5) % predicted, p &lt; 0.001) than Group II. Exercise superior vena cava pressures were higher (16 [14–22.5] vs. 5.5 [3–7.3] mmHg, p &lt; 0.001) and arterial oxygen saturation lower (89% [85–93] vs. 97% [96–98], p &lt; 0.001) in Group II compared to NCD, while no differences in PAWP, stroke volume index, heart rate, or Qs response were seen. If defined as two standard deviations above mean values for Group II, elevated PAWP and mean PA pressure post-Fontan would correspond to 20.6 mmHg and 25.8 mmHg, respectively. Conclusion PAWP &gt;20 mmHg and mean PA pressure &gt;25 mmHg could be used to define elevated values during exercise in adults post-Fontan. The major discrepancy in exercise haemodynamics among Group II compared to controls appears to be the degree of systemic venous hypertension and arterial desaturation.
Comparative analysis of syringes versus pump devices in benchtop aspiration thrombectomy models: A systematic review and meta-analysis
Şenol, Yiğit Can , Orscelik, Atakan , Kobeissi, Hassan , Bilgin, Cem , Ghozy, Sherief , Kadirvel, Ramanathan , Kallmes, David F. , Orscelik, Atakan , Kobeissi, Hassan , Bilgin, Cem , Oliver, Alexander A , Ghozy, Sherief , Kadirvel, Ram , Kallmes, David F , Senol, Yigit Can , Li, Jiahui

Mayo Clinic

Interventional Neuroradiology | December 27, 2023 | Volume: 32 | Issue: 3 | Pages: 891-897

10.1177/15910199231222305 | PMID 38151033 Get It

Background Although direct contact aspiration has emerged as one of the leading techniques for mechanical thrombectomy (MT), there is still ongoing debate about the aspiration/suction pump devices that can optimize recanalization rates. To address this gap, we conducted a meta-analysis comparing the aspiration efficacy of 60 ml syringe and pump devices in benchtop MT models. Methods Systematic literature review was conducted using Medline, Embase, Web of Science, and Scopus in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Outcomes of interest included flow rate and vacuum pressure delivered by a 60 ml syringe and several aspiration pumps. We used a random effects model to calculate the mean difference (MD) with 95% confidence intervals (CIs) and a statistically significant difference was considered as a two-sided p -value of less than 0.05. Results We included six benchtop studies comparing 60 ml syringes and vacuum pumps. Our meta-analysis showed that there were no significant differences in vacuum pressure (MD:0.71inHg, 95% CI: [−0.81;2.23], p = 0.359) and flow rate (MD:0.27 mL/s, 95% CI: [−3,07; 3.61], p = 0.873) between 60 ml syringes and vacuum pumps groups. Conclusions Our study demonstrated comparable performance in terms of vacuum pressure and flow rates between a 60 ml syringe and a heterogeneous combination of commercially available aspiration pumps.